Dubai-based healthcare investor Everest Health Investments LLC (“Everest Health”) today announced a strategic collaboration with global AI-powered claims analytics provider Mains Lab W.L.L (“Mains Lab”) to introduce advanced artificial intelligence technology aimed at combating fraud, waste, and claims leakage in the UAE health system. Mains Lab operates across the Middle East, Europe, Latin America, and […] The post Everest Health and Mains Lab Join Forces to Combat Fraud, Waste and Claims Leakage in UAE Healthcare Using AI appeared first on Web-Release.

    Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabart mipitecan (LY4170156) for the treatment of adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received prior bevacizumab and mirvetuximab soravtansine, if eligible. Sofetabart mipitecan is a […] The post Lilly’s sofetabart mipitecan receives U.S. FDA’s Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer appeared first on Web-Release.